CARM
Carisma Therapeutics
CARM
CARM
Delisted
CARM was delisted on the 10th of October, 2025.
27 hedge funds and large institutions have $10.9M invested in Carisma Therapeutics in 2018 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
25% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 4
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $63K
Holders
27
Holding in Top 10
1
Calls
–
Puts
$63K
Top Buyers
| 1 | +$1.67M | |
| 2 | +$1.29M | |
| 3 | +$1.27M | |
| 4 |
Millennium Management
New York
|
+$258K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$116K |
Top Sellers
| 1 | -$400K | |
| 2 | -$196K | |
| 3 | -$53K | |
| 4 |
TSS
Two Sigma Securities
New York
|
-$53K |
| 5 |
WS
Wedbush Securities
Los Angeles,
California
|
-$13K |